Cargando…

Pharmacogenetics in the clinic

Detalles Bibliográficos
Autor principal:	Guchelaar, H.-J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041302/ http://dx.doi.org/10.1016/j.ejcsup.2013.07.051

Ejemplares similares

Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics
por: Perwitasari, D. A., et al.
Publicado: (2011)

Estimated nationwide impact of implementing a preemptive pharmacogenetic panel approach to guide drug prescribing in primary care in The Netherlands
por: Bank, P. C. D., et al.
Publicado: (2019)

Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
por: Caudle, Kelly E., et al.
Publicado: (2019)

Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Pharmacist-Initiated Pre-Emptive Pharmacogenetic Panel Testing with Clinical Decision Support in Primary Care: Record of PGx Results and Real-World Impact
por: van der Wouden, Cathelijne H., et al.
Publicado: (2019)

Repurposing of Diagnostic Whole Exome Sequencing Data of 1,583 Individuals for Clinical Pharmacogenetics
por: van der Lee, Maaike, et al.
Publicado: (2019)

Pharmacogenetics in Psychiatry: An Update on Clinical Usability
por: van Schaik, Ron H. N., et al.
Publicado: (2020)

Influence of pharmacogenetic variability on the pharmacokinetics and toxicity of the aurora kinase inhibitor danusertib
por: Steeghs, Neeltje, et al.
Publicado: (2010)

Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings
por: Smith, D. Max, et al.
Publicado: (2020)

Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
por: Pritchard, Daryl, et al.
Publicado: (2022)

Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib‐Treated Cancer
por: Diekstra, MH, et al.
Publicado: (2017)

Association Studies in Clinical Pharmacogenetics
por: Zubiaur, Pablo, et al.
Publicado: (2022)

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients
por: Moes, D. J. A. R, et al.
Publicado: (2015)

Pharmacogenetic testing in the Veterans Health Administration: Policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee
por: Vassy, Jason L., et al.
Publicado: (2018)

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19
por: Swen, J. J., et al.
Publicado: (2011)

Cancer pharmacogenetics
por: Marsh, S, et al.
Publicado: (2004)

Correction to: Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines
Publicado: (2022)

Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC)
por: Caudle, Kelly E., et al.
Publicado: (2017)

Pharmacogenetics of tacrolimus: ready for clinical translation?
por: Coto, Eliecer, et al.
Publicado: (2011)

Clinical Relevance of Pharmacogenetics in Serotonin Syndrome
por: Pandya, Dehuti, et al.
Publicado: (2020)

Pharmacogenetics of Anticoagulants
por: Rane, Anders, et al.
Publicado: (2010)

Pharmacogenetics of osteoporosis
por: Marini, Francesca, et al.
Publicado: (2010)

Pharmacogenetics of Cannabinoids
por: Hryhorowicz, Szymon, et al.
Publicado: (2017)

Development of the PGx‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing
por: van der Wouden, Cathelijne H., et al.
Publicado: (2019)

Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx)
por: Just, Katja Susanne, et al.
Publicado: (2017)

Towards the clinical implementation of pharmacogenetics in bipolar disorder
por: Salloum, Naji C, et al.
Publicado: (2014)

Encountering Pharmacogenetic Test Results in the Psychiatric Clinic
por: Bousman, Chad A, et al.
Publicado: (2021)

Experimental Pharmacogenetics
por: Lubs, Herbert A.
Publicado: (1964)

The pharmacogenetics of imatinib
por: Dulucq, Stéphanie, et al.
Publicado: (2010)

Pharmacogenetics of Antidepressants
por: Crisafulli, Concetta, et al.
Publicado: (2011)

Pharmacogenetics of thiopurines
por: Franca, Raffaella, et al.
Publicado: (2019)

Pharmacogenetics of Antiplatelet Drugs
por: Curtin, Ronan, et al.
Publicado: (2002)

Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines
por: Lunenburg, Carin A. T. C., et al.
Publicado: (2019)

Clinical Application of Pharmacogenetics: Where are We Now?
por: van Schaik, Ron HN
Publicado: (2014)

Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors
por: Steeghs, Neeltje, et al.
Publicado: (2009)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Digital Health Applications for Pharmacogenetic Clinical Trials
por: Naik, Hetanshi, et al.
Publicado: (2020)

Clinical pharmacology and pharmacogenetics of prostaglandin analogues in glaucoma
por: Zhou, Lin, et al.
Publicado: (2022)

Pharmacogenetics – Getting Closer
por: MacDonald, Ian M
Publicado: (2009)

Pharmacogenetic research in Kazakhstan
por: Zholdybayeva, Elena, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_645mi3f3467q7v3002faig61bj